We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+3.98%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$29.9B
AUM Growth
+$1.03B
(+3.6%)
Cap. Flow
+$181M
Cap. Flow
% of AUM
0.61%
Top 10 Holdings %
Top 10 Hldgs %
19.41%
Holding
1,859
New
106
Increased
777
Reduced
753
Closed
113
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$174M |
| 2 |
Healthpeak Properties
DOC
|
+$98.8M |
| 3 |
Williams Companies
WMB
|
+$71.3M |
| 4 |
Amazon
AMZN
|
+$61.5M |
| 5 |
Ventas
VTR
|
+$61.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$210M |
| 2 |
Vodafone
VOD
|
+$120M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$91.7M |
| 4 |
LyondellBasell Industries
LYB
|
+$67.5M |
| 5 |
DexCom
DXCM
|
+$57.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.83% |
| 2 | Consumer Staples | 12.27% |
| 3 | Energy | 9.9% |
| 4 | Financials | 8.88% |
| 5 | Industrials | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
JPMorgan Chase
JPM
$929B
| $211M | 0.7% |
3,471,417
+253,058
| +8% | +$14.6M |
|
|
27
AbbVie
ABBV
$470B
| $208M | 0.7% |
4,049,071
-4,148,900
| -51% | -$210M |
|
|
RDS.B
28
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $199M | 0.66% |
2,542,087
+18,360
| +0.7% | +$1.39M |
|
|
29
LyondellBasell Industries
LYB
$19.6B
| $193M | 0.64% |
2,169,050
-802,209
| -27% | -$67.5M |
|
30
Pfizer
PFE
$143B
| $187M | 0.62% |
6,128,277
-1,529,978
| -20% | -$45.6M |
|
|
CBST
31
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $185M | 0.62% |
2,533,328
+226,893
| +10% | +$16.9M |
|
|
32
DexCom
DXCM
$29.3B
| $185M | 0.62% |
17,895,060
-5,599,468
| -24% | -$57.9M |
|
33
GSK
GSK
$106B
| $180M | 0.6% |
2,692,591
+148,359
| +6% | +$10M |
|
34
Halliburton
HAL
$26.2B
| $178M | 0.6% |
3,027,235
+22,371
| +0.7% | +$1.19M |
|
35
American Electric Power
AEP
$70.8B
| $172M | 0.57% |
3,386,940
-869
| -0% | -$42.2K |
|
36
Alkermes
ALKS
$8.27B
| $157M | 0.52% |
3,554,591
-43,962
| -1% | -$2.09M |
|
|
37
Healthpeak Properties
DOC
$15.5B
| $154M | 0.51% |
4,355,018
+2,860,168
| +191% | +$98.8M |
|
38
Whirlpool
WHR
$2.49B
| $148M | 0.5% |
991,717
+45,672
| +5% | +$6.61M |
|
|
SLXP
39
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $148M | 0.49% |
1,429,172
-377,805
| -21% | -$38.7M |
|
40
Procter & Gamble
PG
$338B
| $146M | 0.49% |
1,805,348
-6,145
| -0.3% | -$484K |
|
41
PepsiCo
PEP
$196B
| $145M | 0.48% |
1,736,334
-19,404
| -1% | -$1.58M |
|
42
Bristol-Myers Squibb
BMY
$130B
| $139M | 0.46% |
2,667,012
+28,325
| +1% | +$1.51M |
|
|
DYAX
43
DELISTED
DYAX CORPORATION
DYAX
| $132M | 0.44% |
14,643,737
-1,085,200
| -7% | -$9.87M |
|
44
Biogen
BIIB
$30.7B
| $130M | 0.43% |
423,937
+751
| +0.2% | +$238K |
|
45
Corning
GLW
$112B
| $129M | 0.43% |
6,177,926
+1,270,690
| +26% | +$23.9M |
|
|
ESRX
46
DELISTED
Express Scripts Holding Company
ESRX
| $126M | 0.42% |
1,680,370
-1,225,015
| -42% | -$91.7M |
|
47
NXP Semiconductors
NXPI
$63.3B
| $122M | 0.41% |
2,077,900
-223,800
| -10% | -$11.7M |
|
|
CBI
48
DELISTED
Chicago Bridge & Iron Nv
CBI
| $119M | 0.4% |
1,364,395
+71,795
| +6% | +$5.83M |
|
|
49
Vodafone
VOD
$37.3B
| $115M | 0.39% |
3,136,676
-3,117,486
| -50% | -$120M |
|
50
CVS Health
CVS
$137B
| $114M | 0.38% |
1,529,010
-145,436
| -9% | -$10.3M |
|
Similar funds
Federated Hermes's Q1 2014 Portfolio in Review
As of Q1 2014, Federated Hermes held 1,859 positions worth $29.9B, up 3.6% from $28.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Federated Hermes's Q1 2014 filing shows 106 new, 777 increased, 753 reduced and 113 closed positions. Its largest new stake was Colony Capital, Inc.: 1,465,448 shares worth $32.2M. The largest sale was AbbVie, an estimated $210M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Energy.
- Federated Hermes's largest Q1 2014 buy was Colony Capital, Inc.: 1,465,448 shares worth $32.2M.
- Federated Hermes added most to Philip Morris in Q1 2014, an estimated $174M increase.
- Federated Hermes's biggest Q1 2014 reduction was AbbVie, cutting an estimated $210M.
- Federated Hermes fully exited Sinclair Inc in Q1 2014, selling an estimated $36.1M.
- Federated Hermes's ten largest holdings make up 19% of its $29.9B portfolio in Q1 2014.
- Federated Hermes opened 106 new positions and closed 113 in Q1 2014.
- Federated Hermes's portfolio value rose 3.6% quarter-over-quarter to $29.9B.
Based on Federated Hermes's 13F filing for Q1 2014, filed 6 May 2014.